Subscribe
Home
Articles
Latest News
Special Issues
Browse By Topic
Early Diagnosis
Misdiagnosis
Web Exclusives
All Videos
Interview with the Innovators
Master Class Series
Clinical Crossfire
Supported by BridgeBio
2021
Unraveling the Complexities of Transthyretin Amyloidosis (ATTR)
Advanced Practice Providers’ Clinical Practice Guide for ATTR-CM
Advanced Practice Providers’ Clinical Practice Guide for ATTR-CM
Utility of Functional Assessments in the Prognosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
By
Amy Brownell, MSN, FNP-C, AACC
;
Sarah C. Paciulli, MS, RN, CHFN, NP-C
;
Lori Roth, MS, PA-C
Interview with the Innovators
Videos
Amy Brownell, MSN, FNP-C, AACC, System Director of Heart Failure, AMITA Health, Chicago, IL; Sarah C. Paciulli, MS, RN, CHFN, NP-C, VCU Health, Richmond, VA; and Lori Roth, MS, PA-C, Advanced Heart Failure Clinic, UT Southwestern Medical Center, Dallas TX, explain the usefulness of the six-minute walk test in clinical practice and to patients.
Advanced Practice Providers’ Clinical Practice Guide for ATTR-CM
Addressing Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Through Preservation of Transthyretin
By
Amy Brownell, MSN, FNP-C, AACC
;
Sarah C. Paciulli, MS, RN, CHFN, NP-C
;
Lori Roth, MS, PA-C
Interview with the Innovators
Videos
Lori Roth, MS, PA-C, Advanced Heart Failure Clinic, UT Southwestern Medical Center, Dallas, TX; Sarah C. Paciulli, MS, RN, CHFN, NP-C, VCU Health, Richmond, VA; and Amy Brownell, MSN, FNP-C, AACC, System Director of Heart Failure, AMITA Health, Chicago, IL, review the rationale for stabilization as the optimal approach to addressing transthyretin amyloid cardiomyopathy.
Advanced Practice Providers’ Clinical Practice Guide for ATTR-CM
The Journey to Diagnosing Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Doesn’t Have to Be a Long One
By
Amy Brownell, MSN, FNP-C, AACC
;
Sarah C. Paciulli, MS, RN, CHFN, NP-C
;
Lori Roth, MS, PA-C
Interview with the Innovators
Videos
Lori Roth, MS, PA-C, Advanced Heart Failure Clinic, UT Southwestern Medical Center, Dallas, TX; Sarah C. Paciulli, MS, RN, CHFN, NP-C, VCU Health, Richmond, VA; and Amy Brownell, MSN, FNP-C, AACC, System Director of Heart Failure, AMITA Health, Chicago, IL, discuss the debilitating disease burden and the pathway to transthyretin amyloid cardiomyopathy diagnosis.
Advanced Practice Providers’ Clinical Practice Guide for ATTR-CM
Transthyretin (TTR) Protein in Humans: Stabilization vs Destabilization
By
Amy Brownell, MSN, FNP-C, AACC
;
Sarah C. Paciulli, MS, RN, CHFN, NP-C
;
Lori Roth, MS, PA-C
Interview with the Innovators
Videos
In this first video clip, Sarah C. Paciulli, MS, RN, CHFN, NP-C, VCU Health, Richmond, VA; Amy Brownell, MSN, FNP-C, AACC, System Director of Heart Failure, AMITA Health, Chicago, IL; and Lori Roth, MS, PA-C, Advanced Heart Failure Clinic, UT Southwestern Medical Center, Dallas, TX, describe the functions of transthyretin (TTR) in its naturally occurring tetrameric form and resulting damage from TTR destabilization.
Unraveling the Complexities of Transthyretin Amyloidosis (ATTR)
Serum Transthyretin in the Management of TTR Amyloidosis
By
Justin L. Grodin, MD, MPH
Interview with the Innovators
Videos
Justin L. Grodin, MD, MPH, Assistant Professor of Medicine, UT Southwestern Medical Center, Dallas, TX, explains the current and potentially future utilities of serum transthyretin (sTTR) as a biomarker in the management of transthyretin amyloidosis.
Unraveling the Complexities of Transthyretin Amyloidosis (ATTR)
Setting Realistic Treatment Goals and Expectations for Patients with Transthyretin Amyloidosis
By
Ola Akinboboye, MD, MPH, MBA
;
Clement C. Eiswirth, Jr., MD, FACC
Interview with the Innovators
Videos
Ola Akinboboye, MD, MPH, MBA, Clinical Professor, Cardiology, Donald and Barbara Zucker School of Medicine at Hofstra University/Northwell Health and Medical Director, Laurelton Heart Specialists PC (Rosedale, NY) and Clement C. Eiswirth, Jr., MD, FACC, Medical Director, Cardiomyopathy and Heart Failure Program, Ochsner Health, New Orleans, LA, highlight the importance of early diagnosis and realistic expectations for patients being treated for transthyretin amyloidosis.
Unraveling the Complexities of Transthyretin Amyloidosis (ATTR)
Recognizing Clinical Clues of ATTR-CM
By
Clement C. Eiswirth, Jr., MD, FACC
Interview with the Innovators
Videos
Clement C. Eiswirth, Jr., MD, FACC, Medical Director, Cardiomyopathy and Heart Failure Program, Ochsner Health, New Orleans, LA, examines clinical hints for consideration in the diagnosis of ATTR-CM.
Unraveling the Complexities of Transthyretin Amyloidosis (ATTR)
Evoking Suspicion of ATTR-CM: Warning Signs
By
Clement C. Eiswirth, Jr., MD, FACC
Interview with the Innovators
Videos
Clement C. Eiswirth, Jr., MD, FACC, Medical Director, Cardiomyopathy and Heart Failure Program, Ochsner Health, New Orleans, LA, offers warning signs of ATTR-CM to consider for patients with heart failure.
Unraveling the Complexities of Transthyretin Amyloidosis (ATTR)
Complexities of Transthyretin Amyloid Disposition
By
Joel N. Buxbaum, MD
Interview with the Innovators
Videos
Joel N. Buxbaum, MD, Professor Emeritus, Molecular Medicine, The Scripps Research Institute, and Chief Medical Officer (consulting), Protego Biopharma, explores the mechanisms of organ damage in TTR amyloidosis (ATTR). This important information focuses on the biophysical and biochemical underpinnings of misfolded transthyretin (TTR) leading to tissue dysfunction in this disease.
Unraveling the Complexities of Transthyretin Amyloidosis (ATTR)
Transthyretin (TTR) Amyloidosis: Current Diagnostic Approaches in the Clinic
By
Justin L. Grodin, MD, MPH
Interview with the Innovators
Videos
Justin L. Grodin, MD, MPH, Assistant Professor of Medicine, UT Southwestern Medical Center (Dallas, TX), presents a diagnostic algorithmic approach for the establishment of a firm diagnosis of ATTR, with a focus on ATTR patients with heart manifestations (cardiomyopathy).
Page 1 of 2
1
2
Home
Articles
Latest News
Special Issues
Browse By Topic
Early Diagnosis
Misdiagnosis
Web Exclusives
All Videos
Interview with the Innovators
Master Class Series
Clinical Crossfire
Subscribe to Amyloidosis News
Stay up to date with Amyloidosis News by subscribing to receive the free
AMN
e‑Newsletter.
First Name*
Last Name*
Email*
Country*
-- Please Select --
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia, Plurinational State of
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, the Democratic Republic of the
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, the former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena, Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten (Dutch part)
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela, Bolivarian Republic of
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Please verify your request*
SUBSCRIBE